Journal of the American Heart Association·18 SepReal-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events: A Cohort StudyStudy in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovReal-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular DiseaseStudy in peopleInterventionsPaper